FDA recall Z-0737-2022

Philips Healthcare · Class II · device

Product

Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software release R2.x

Reason for recall

Due to an incorrect configuration setting in the EPX database of StentBoost Live, acquisition does not stop automatically as it should. When the user selects the StentBoost Live protocol on the Philips Azurion system, the following on-screen message is displayed to the user in the Philips StentBoost Live application: "Press the cine pedal until the acquisition stops". However, due to the incorrect configuration of the EPX database, the acquisition does not stop after 40 images, but instead it continues as long as the pedal is pressed.

Distribution

US Nationwide distribution.

Key facts

Status
Terminated
Initiation date
2022-02-02
Report date
2022-04-13
Termination date
2024-11-05
Voluntary/Mandated
FDA Mandated
Location
Andover, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0737-2022